|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/30/21 4D Pharma plc 20-F/A 12/31/20 75:6.9M M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size
1: 20-F/A Amendment to Annual or Annual-Transition Report by HTML 1.21M
a Foreign Non-Canadian Issuer
4: EX-13.1 Annual or Quarterly Report to Security Holders HTML 22K
5: EX-13.2 Annual or Quarterly Report to Security Holders HTML 22K
2: EX-12.1 Statement re: the Computation of Ratios HTML 27K
3: EX-12.2 Statement re: the Computation of Ratios HTML 27K
12: R1 Document and Entity Information HTML 61K
13: R2 Consolidated Balance Sheets HTML 104K
14: R3 Consolidated Balance Sheets (Parenthetical) HTML 30K
15: R4 Consolidated Statements of Operations and HTML 84K
Comprehensive Loss
16: R5 Consolidated Statements of Stockholders' Equity HTML 59K
17: R6 Consolidated Statements of Cash Flows HTML 102K
18: R7 Nature of the Business HTML 30K
19: R8 Summary of Significant Accounting Policies HTML 78K
20: R9 Prepayments and Other Current Assets HTML 27K
21: R10 Property and Equipment HTML 29K
22: R11 Goodwill and Intangible Assets HTML 47K
23: R12 Leases HTML 36K
24: R13 Accrued Expenses and Other Current Liablities HTML 29K
25: R14 Commitments and Contingencies HTML 27K
26: R15 Stockholders' Equity HTML 53K
27: R16 Revenue HTML 31K
28: R17 Contingent Consideration HTML 34K
29: R18 Income Taxes HTML 64K
30: R19 Related Party Transactions HTML 26K
31: R20 Subsequent Events HTML 32K
32: R21 Summary of Significant Accounting Policies HTML 131K
(Policies)
33: R22 Summary of Significant Accounting Policies HTML 34K
(Tables)
34: R23 Prepayments and Other Current Assets (Tables) HTML 27K
35: R24 Property and Equipment (Tables) HTML 29K
36: R25 Goodwill and Intangible Assets (Tables) HTML 51K
37: R26 Leases (Tables) HTML 34K
38: R27 Accrued Expenses and Other Current Liablities HTML 29K
(Tables)
39: R28 Stockholders' Equity (Tables) HTML 50K
40: R29 Contingent Consideration (Tables) HTML 28K
41: R30 Income Taxes (Tables) HTML 65K
42: R31 Nature of the Business (Details Narrative) HTML 71K
43: R32 Summary of Significant Accounting Policies HTML 50K
(Details Narrative)
44: R33 Summary of Significant Accounting Policies - HTML 27K
Schedule of Business Combination Measured at Fair
Value (Details)
45: R34 Summary of Significant Accounting Policies - HTML 31K
Schedule of Estimated Useful Lives of the Assets
(Details)
46: R35 Summary of Significant Accounting Policies - HTML 26K
Schedule of Net Income Loss Per Share (Details)
47: R36 Prepayments and Other Current Assets - Schedule of HTML 32K
Prepayments and Other Current Assets (Details)
48: R37 Property and Equipment (Details Narratives) HTML 24K
49: R38 Property and Equipment - Schedule of Property and HTML 33K
Equipment (Details)
50: R39 Goodwill and Intangible Assets (Details Narrative) HTML 29K
51: R40 Goodwill and Intangible Assets - Schedule of HTML 27K
Goodwill (Details)
52: R41 Goodwill and Intangible Assets - Schedule of HTML 52K
Intangible assets (Details)
53: R42 Goodwill and Intangible Assets - Schedule of HTML 35K
Estimated Amortization Expense (Details)
54: R43 Leases (Details Narrative) HTML 35K
55: R44 Leases - Schedule of Leases (Details) HTML 34K
56: R45 Leases - Schedule of Maturities of Operating Lease HTML 41K
Liabilities (Details)
57: R46 Accrued Expenses and Other Current Liablities - HTML 43K
Schedule of Accrued Expenses and Other Current
Liabilities (Details)
58: R47 Stockholders' Equity (Details Narrative) HTML 111K
59: R48 Stockholders' Equity - Schedule of Common Stock HTML 28K
Warrant Activity (Details)
60: R49 Stockholders' Equity - Summary of Stock Option HTML 71K
Activity (Details)
61: R50 Stockholders' Equity - Schedule of HTML 32K
Weighted-average Assumptions Used in Black-scholes
Valuation Method (Details)
62: R51 Revenue (Details Narrative) HTML 44K
63: R52 Contingent Consideration (Details Narrative) HTML 44K
64: R53 Contingent Consideration - Schedule of Contingent HTML 34K
Consideration (Details)
65: R54 Income Taxes (Details Narrative) HTML 40K
66: R55 Income Taxes - Schedule of Loss Before Income Tax HTML 32K
Benefit (Details)
67: R56 Income Taxes - Schedule of Effective Tax Rates HTML 62K
Reconciliation (Details)
68: R57 Income Taxes - Schedule of Income Tax Benefit HTML 31K
(Details)
69: R58 Income Taxes - Schedule of Deferred Tax Liability HTML 38K
(Details)
70: R59 Income Taxes - Schedule of Research and HTML 33K
Development Tax Credits (Details)
71: R60 Related Party Transactions (Details Narrative) HTML 38K
72: R61 Subsequent Events (Details Narrative) HTML 106K
74: XML IDEA XML File -- Filing Summary XML 136K
73: EXCEL IDEA Workbook of Financial Reports XLSX 101K
6: EX-101.INS XBRL Instance -- dddd-20201231 XML 1.27M
8: EX-101.CAL XBRL Calculations -- dddd-20201231_cal XML 192K
9: EX-101.DEF XBRL Definitions -- dddd-20201231_def XML 484K
10: EX-101.LAB XBRL Labels -- dddd-20201231_lab XML 982K
11: EX-101.PRE XBRL Presentations -- dddd-20201231_pre XML 774K
7: EX-101.SCH XBRL Schema -- dddd-20201231 XSD 146K
75: ZIP XBRL Zipped Folder -- 0001493152-21-010214-xbrl Zip 137K
 | Download this zipped .zip folder |
| Files: | dddd-20201231.xml dddd-20201231.xsd dddd-20201231_cal.xml dddd-20201231_def.xml dddd-20201231_lab.xml dddd-20201231_pre.xml |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/02/21 4D Pharma plc 20-F 12/31/20 77:7.1M M2 Compliance LLC/FA 2/18/21 JPMorgan Chase Bank N… Depositary F-6 3:319K 4D Pharma plc E-Data Systems, Inc./FA 2/16/21 4D Pharma plc F-4/A 12:12M Toppan Merrill/FA 1/28/21 4D Pharma plc F-4/A 17:100M Toppan Merrill/FA 1/08/21 4D Pharma plc F-4/A 7:12M Toppan Merrill/FA 11/25/20 4D Pharma plc F-4 8:12M Toppan Merrill/FA |